Brief: Biofrontera AG Says FY 2022 Total Revenue Amounted To EUR 25.7 Million
27/04/2023 22:24
April 27 (Reuters) - Biofrontera AG B8FGn.DE :
* FY 2022 TOTAL REVENUE AMOUNTED TO EUR 25.7 MILLION
* FY 2022 EBITDA AMOUNTED TO EUR 1.9 MILLION
* GROUP EXPECTS SALES OF EUR 27 TO 33 MILLION IN FISCAL YEAR
2023
* EXPECTS POSITIVE EBITDA OF EUR 3 TO 5 MILLION AND POSITIVE
EBIT
OF EUR 2 TO 4 MILLION IN 2023
* EXPECTS FURTHER SALES INCREASES AS WELL AS POSITIVE EBITDA
AND
EBIT IN MID SINGLE-DIGIT MILLION RANGE FROM 2024 ONWARDS
* BIOFRONTERA - HAS SUFFICIENT LIQUIDITY IN COMING 12 MONTHS
WITH
A LEVEL OF CASH AND CASH EQUIVALENTS OF EUR 6.4 MILLION IN GROUP
AS OF DECEMBER 31, 2022
Source text for Eikon: ID:nPex8sPKxa
Further company coverage: B8FGn.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biofrontera AG
See all newsBrief: Biofrontera Says Co And Units Have Entered Into An Agreement With Biofrontera Inc About How To Settle Payment Obligations By Biofrontera Inc
Brief: Biofrontera AG Says Legal Dispute On Import In USA Will Result In Revised Outlook
Brief: Biofrontera AG Resolves Capital Increase From Authorized Capital
Brief: Biofrontera AG Says Plans Capital Reduction And Considers Subsequent Capital Increase From Authorized Capital
Brief: Biofrontera AG Says FY 2022 Total Revenue Amounted To EUR 25.7 Million